Research Institute of the McGill University Health Centre (RI-MUHC)

Two cellular pathways involved in TNBC tumour development and a promising targeted combination therapy

Published: 3Jun2021

A team of researchers at the RI-MUHC found two cellular pathways involved in TNBC tumour development and a promising targeted combination therapy Source: RI-MUHC

Back to top